Randomized Trial of Follow-up Strategies in Breast Cancer
Breast Cancer
About this trial
This is an interventional prevention trial for Breast Cancer focused on measuring Breast Cancer, Follow-up Strategy, Follow-up Care, Family Physician, Oncologist
Eligibility Criteria
Inclusion Criteria: Women with breast cancer on well follow-up at regional cancer centres in Ontario and Manitoba Diagnosed at least 12 months previously (range 9-15 months) Without evidence of active disease (i.e., stages IIIB and IV excluded) Free from any primary treatment complications Exclusion Criteria: Primary treatment at least 3 months previously, except for continued use of tamoxifen Still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window) Unable to identify an acceptable family physician to provide follow-up Language or literacy skills inconsistent with completing questionnaires Unable to comply with study protocol including completion of questionnaires Previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics Actively followed at a cancer centre for another primary cancer
Sites / Locations
- Juravinski Cancer Centre
- Kingston Regional Cancer Centre
- Ottawa Hospital - Integrate Cancer Program
- Thunder Bay Regional Health Sciences Centre
- Toronto Sunnybrook Hospital